跳至主要内容
临床试验/NCT05193669
NCT05193669进行中(未招募)不适用

VALidation of Tests Usable as a First Step TRIage to Manage Women Positive to High-risk Papillomavirus

Hiantis Srl1 个研究点 分布在 1 个国家目标入组 23,941 人开始时间: 2021年4月14日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
23,941
试验地点
1
主要终点
Sensitivity of the index triage test: Pap-test

研究概览

简要总结

Women accessing the HPV-based screening programme for primary screening, will undergo cervical sampling and clinical data recording. Samples from high-risk HPV positive women (around 2000 expected) will be aliquoted for testing with new HPV molecular test, that will allow full genotyping and viral load quantification.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
25 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women participating in a cervical cancer screening program using an HPV assay as primary screening test
  • positivity to hrHPV;
  • written informed consent given.

排除标准

  • total hysterectomy;
  • diagnosis of CIN2+ in the last two years;
  • hrHPV negative or inadequate.

结局指标

主要结局

Sensitivity of the index triage test: Pap-test

时间窗: Baseline

Sensitivity of the index triage test(s) performed at the time of reflex testing for CIN2+ and CIN3+ detected at the time of reflex triage and relative sensitivity (index vs comparator)

Sensitivity of the index and comparator triage test: HPV molecular test

时间窗: Baseline

Sensitivity of the index and comparator triage test(s) performed at the time of reflex testing for CIN2+ and CIN3+ detected at the time of reflex triage + delayed triage; and relative sensitivity (index vs comparator).

Specificity of the index and comparator triage test

时间窗: Month 12

Specificity of the index and comparator triage test(s) performed at the time of reflex testing for \<CIN2 considered at the time of reflex triage accepting negative colposcopy at the time of reflex testing and double negative index triage testing (reflex and delayed) as an acceptable proxy for \<CIN2 and relative specificity for \<CIN2 (index vs comparator).

次要结局

未报告次要终点

研究者

发起方
Hiantis Srl
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验